Catalyst Biosciences - 50 Year Dividend History | CBIO
Historical dividend payout and yield for Catalyst Biosciences (CBIO) since 1971. The current TTM dividend payout for Catalyst Biosciences (CBIO) as of September 24, 2021 is $0.00. The current dividend yield for Catalyst Biosciences as of September 24, 2021 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.149B |
$0.021B |
|
Catalyst Biosciences, Inc. is a biopharmaceutical company which focused on creating and developing medicines to address serious medical conditions. The Company's hemostasis product candidates include CB 813d/PF-0520602, CB 2679d/ISU 304 and FXa. Anti-Complement Product consists of CB 2782 and Ophthalmic which are in clinical different trail. Catalyst Biosciences, Inc., formerly known as Targacept, Inc., is based in South San Francisco, Calif.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
